Related Experiment Videos
Decreased CD4+CD29+ (memory T) cells in patients with chronic granulomatous disease
M Hasui1, K Hattori, S Taniuchi
1Department of Pediatrics, Kansai Medical University, Osaka, Japan.
Insights
Chronic granulomatous disease (CGD) patients show decreased memory T cells, impacting immune function. This finding may explain why interferon-gamma (IFN-gamma) therapy is effective in treating CGD infections.
Area of Science:
- Immunology
- Hematology
- Cell Biology
Background:
- Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by impaired phagocyte function.
- T lymphocyte subsets, crucial for adaptive immunity, may be affected in CGD.
- Interferon-gamma (IFN-gamma) therapy is an established treatment for reducing serious infections in CGD patients.
Purpose of the Study:
- To investigate lymphocyte subset abnormalities in patients with chronic granulomatous disease (CGD).
- To explore the potential relationship between T lymphocyte subset changes and the therapeutic efficacy of IFN-gamma in CGD.
Main Methods:
- Flow cytometry was utilized to analyze lymphocyte subsets in 17 CGD patients and age-matched controls.
- Specific subsets examined included CD4+CD29+ (memory T cells) and CD8+CD11b+ (suppressor T cells).
Main Results:
- CGD patients exhibited significantly decreased levels of memory T cells (CD4+CD29+) and suppressor T cells (CD8+CD11b+).
- These T cell subsets remained largely unchanged with age in CGD patients, unlike the gradual increase observed in healthy controls.
- An abnormality in T lymphocyte maturation was suggested in CGD.
Conclusions:
- Reduced memory T cell populations in CGD patients may contribute to their compromised immune response.
- The deficiency in memory T cells could elucidate the mechanism behind the therapeutic benefits of IFN-gamma in CGD.
- Further research is warranted to fully understand the immunopathogenesis of CGD and optimize treatment strategies.
Abstract:
By the use of flow cytometry, 17 patients with chronic granulomatous disease (CGD) were examined for lymphocyte subsets. CD4+CD29+ cell (memory T cell) and CD8+CD11b+ cell (suppressor T cell) subsets in CGD were significantly decreased and remained practically unchanged throughout the period examined except in those < 6 months of age, although in controls both subsets gradually increased with age. These data indicate a certain abnormality in the maturation process of CGD T lymphocytes. Memory T cells are known to secrete a large amount of interferon-gamma (IFN-gamma). Recently, administration of IFN-gamma to CGD patients has become an effective treatment that reduces the frequency of serious bacterial infections. Decreased memory T cells may clarify the mechanism of therapeutic effectiveness, which remains unknown.